Abstract
Introduction
In this report, we present a case of iatrogenic hyperadrenocorticism and steatohepatitis caused by the intake of an unapproved medicine. Recently 
T a b l e 2 . L a b o r a t o r y Da t a ( 2 ) active insulin (SIRI) levels were within normal limits upon application of betamethasone valerate (BM) to the psoriasis lesions at 50-60 mg/day for 10 days. However, they also reported that when the applied glucocorticoid was changed to DOM at 125-150 mg/day, the fasting PG level and the fasting SIRI/PG ratio increased markedly with the suppression of urinary free F concentration to below the detection limit, and that the ratio of total fluctuations of PG and SIRI (∆SIRI/∆PG) in a 100-gram oral glucose tolerance test was 7.09 with DOM application, whereas it was 2.07 with BM application. In addition, Garden and Freinkel reported the cases of 5 psoriasis patients who applied DOM to the psoriasis lesions at 72.5-282.5 mg/day for 5 days (5). They reported that, in all the patients, the serum F level in the early morning, which was 10-17 μg/dL before DOM application, decreased to below 2 μg/dL 24 hours after DOM application, and then to below 4 μg/dL 3 days after DOM discontinuation. Moreover, the fasting PG level increased and decreased significantly during the DOM application period and 3 days after DOM discontinuation, respectively. Meanwhile, the fasting SIRI level and the fasting SIRI/PG ratio increased significantly both during the DOM application period and after discontinuation. These reports suggest that iatrogenic hyperadrenocorticism occurs and insulin resistance worsens when a large dose of DOM is applied.
In the present patient, we did not consider that DXM suppressed internal adrenocorticism because the concentration of DXM in the "Agent" capsules was low. Our analysis revealed that the "Agent" contained a high concentration of DOM in addition to the DXM. Thus, we considered that the DOM in the "Agent" caused the suppression of internal adrenocortical function and iatrogenic hyperadrenocorticism in our patient.
Concerning the liver damage observed in the present pa- 
F i g u r e 2 . Cl i n i c a l c o u r s e . I t a l i c s r e p r e s e n t me d i c a t i o n s . T h e r e s u l t s o f t h e r a p i d a d r e n o c o r t i c o t r o p i c h o r mo n e s t i mu l a t i o n t e s t a r e s h o wn i n t h e l o we r p a n e l .

i d c h r oma t o g r a p h y wi t h a t mo s p h e r i c -p r e s s u r e p h o t o i o n i z a t i o n , B : T i me -o f -f l i g h t ma s s s p e c t r o me t r y . T h e p e a k s a t 3 7 7 . 1 8 8 4 a n d 3 5 7 . 1 8 6 7 o f m/ z i n d i c a t e t h e c o mp o u n d c o mb i n e d wi t h t h e i o n i z e d h y d r o g e n a n d t h e f l u o r i n e -d e t a c h e d r a d i c a l o f t h e c o mp o u n d , r e s p e c t i v e l y . T h u s , t h e mo l e c u l a r we i g h t o f t h e u n k n o wn c o mp o n e n t o f t h e " Ag e n t " i s e s t i ma t e d t o b e a p p r o x i ma t e l y 3 7 6 .
dition, the mechanisms by which excessive glucocorticoids cause NASH should be elucidated in detail in the future.
